EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Trends of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody prevalence in selected regions across Ghana

Peter Kojo Quashie, Joe Kimanthi Mutungi, Francis Dzabeng, Daniel Oduro-Mensah, Precious C. Opurum, Kesego Tapela, Aniefiok John Udoakang, Ivy Asante, Lily Paemka, Frederick Kumi-Ansah, Osbourne Quaye, Emmanuela Amoako und 12 weitere

Wellcome Open Research · 15.01.2026 · 6 · 173

DOI: 10.12688/wellcomeopenres.16890.2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Wellcome Open Research, online erschienen am 15.01.2026. Verfasst von Peter Kojo Quashie und 23 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Francis Crick Institute, National Institute for Health Research, Wellcome Trust.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We set out to estimate the community-level exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Ghana.

Methods

Phased seroprevalence studies of 2729 participants at selected locations across Ghana were conducted. Phase I (August 2020) sampled 1305 individuals at major markets/lorry stations, shopping malls, hospitals and research institutions involved in coronavirus disease 2019 (COVID-19) work. The study utilized a lateral flow rapid diagnostic test (RDT) which detected IgM and IgG antibodies against SARS-CoV-2 nucleocapsid protein.

Results

During Phase I, 252/1305 (19%) tested positive for IgM or IgG or both. Exposure was significantly higher at markets/lorry stations (26.9%) compared to malls (9.4%), with 41–60-year group demonstrating highest seropositivity (27.2%). Exposure was higher in participants with no formal education (26.2%) than those with tertiary education (13.1%); and higher in informally employed workers (24.0%) than those in the formal sector (15.0%). Results from phases II and III, in October and December 2020 respectively, implied either reduced transmissions or loss of antibody expression in some participants. The Upper East region showed the lowest seropositivity (2%). Phase IV, in February 2021, showed doubled seropositivity in the upper income bracket (26.2%) since August 2020, reflective of Ghana’s second wave of symptomatic COVID-19 cases. This suggested that high transmission rates had overcome the initial socioeconomic stratification of exposure risk. Reflective of second wave hospitalisation trends, the 21–40 age group demonstrated modal seropositivity (24.9) in Phase IV whilst 40–60 years and 60+ previously demonstrated highest prevalence.

Conclusions

Overall, the data indicates higher COVID-19 seroprevalence than officially acknowledged, likely implying a considerably lower-case fatality rate than the current national figure of 0.84%. The data also suggests that COVID-19 is predominantly asymptomatic COVID-19 in Ghana. The observed trends mimic clinical trends of infection and imply that the methodology used was appropriate.

Förderung

  • Francis Crick Institute
  • National Institute for Health Research
  • Wellcome Trust
  • World Bank

Zitieren

APA

Quashie, P. K., Mutungi, J. K., Dzabeng, F., Oduro-Mensah, D., Opurum, P. C., Tapela, K., Udoakang, A. J., Asante, I., Paemka, L., Kumi-Ansah, F., Quaye, O., Amoako, E., Armah, R., Kilba, C., Boateng, N. A., Ofori, M., Kyei, G. B., Bediako, Y., Ndam, N., …, & Awandare, G. A. (2026). Trends of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody prevalence in selected regions across Ghana. Wellcome Open Research, 6, 173. https://doi.org/10.12688/wellcomeopenres.16890.2

Vancouver

Quashie PK, Mutungi JK, Dzabeng F, Oduro-Mensah D, Opurum PC, Tapela K, et al. Trends of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody prevalence in selected regions across Ghana. Wellcome Open Research. 2026;6:173. doi:10.12688/wellcomeopenres.16890.2

BibTeX
@article{Quashie2026,
  author = {Quashie, Peter Kojo and Mutungi, Joe Kimanthi and Dzabeng, Francis and Oduro-Mensah, Daniel and Opurum, Precious C. and Tapela, Kesego and Udoakang, Aniefiok John and Asante, Ivy and Paemka, Lily and Kumi-Ansah, Frederick and Quaye, Osbourne and Amoako, Emmanuela and Armah, Ralph and Kilba, Charlyne and Boateng, Nana Afia and Ofori, Michael and Kyei, George B. and Bediako, Yaw and Ndam, Nicaise and Abugri, James and Ansah, Patrick and Ampofo, William K. and Mutapi, Francisca and Awandare, Gordon A.},
  title = {Trends of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody prevalence in selected regions across Ghana},
  journal = {Wellcome Open Research},
  year = {2026},
  volume = {6},
  pages = {173},
  doi = {10.12688/wellcomeopenres.16890.2}
}
Kostenlos starten →